Skip to content
Famciclovir
Famvir (famciclovir) is a small molecule pharmaceutical. Famciclovir was first approved as Famvir on 1994-06-29. It is used to treat aids-related opportunistic infections, chickenpox, herpes genitalis, herpes labialis, and herpes simplex amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Famciclovir
Tradename
Company
Number
Date
Products
FAMVIRNovartisN-020363 DISCN1994-06-29
3 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
famciclovirANDA2018-12-31
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
aids-related opportunistic infections—D017088—
chickenpoxEFO_0007204D002644B01
herpes genitalisEFO_0007282D006558A60
herpes labialisEFO_1001347D006560B00.1
herpes simplex—D006561B00
herpes zosterEFO_0006510D006562B02
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J05: Antivirals for systemic use
— J05A: Direct acting antivirals
— J05AB: Nucleosides and nucleotides excl. reverse transcriptase inhibitors
— J05AB09: Famciclovir
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AD: Antivirals, ophthalmologic
— S01AD07: Famciclovir
HCPCS
No data
Clinical
Clinical Trials
24 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EpilepsyD004827EFO_0000474G40.93181215
SeizuresD012640G40.4——21—3
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postherpetic neuralgiaD051474—1———1
AnhedoniaD059445R45.84—1———1
Depressive disorderD003866EFO_1002014F32.A—1———1
Amyotrophic lateral sclerosisD000690EFO_0000253G12.21—1———1
DepressionD003863F33.9—1———1
Major depressive disorderD003865EFO_0003761F22—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Partial epilepsiesD004828EFO_00042631———12
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFAMCICLOVIR
INNfamciclovir
Description
Famciclovir is 2-Amino-9H-purine in which the hydrogen at position 9 is substituted by a 4-acetoxy-3-(acetoxymethyl)but-1-yl group. A prodrug of the antiviral penciclovir, it is used for the treatment of acute herpes zoster (shingles), for the treatment or suppression of recurrent genital herpes in immunocompetent patients and for the treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients. It has a role as a prodrug and an antiviral drug. It is a member of 2-aminopurines and an acetate ester.
Classification
Small molecule
Drug classantivirals: antivirals (acyclovir type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O
Identifiers
PDB—
CAS-ID104227-87-4
RxCUI68099
ChEMBL IDCHEMBL880
ChEBI ID4974
PubChem CID3324
DrugBankDB00426
UNII IDQIC03ANI02 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,201 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
497 adverse events reported
View more details